[Influenza in children: what should be considered in prevention and treatment?].
Identifieur interne : 000422 ( Main/Exploration ); précédent : 000421; suivant : 000423[Influenza in children: what should be considered in prevention and treatment?].
Auteurs : Hardy-Thorsten Panknin [Allemagne] ; Matthias TrautmannSource :
- Kinderkrankenschwester : Organ der Sektion Kinderkrankenpflege [ 0723-2276 ] ; 2008.
Descripteurs français
- KwdFr :
- Adolescent, Adulte, Adulte d'âge moyen, Allemagne, Antiviraux (effets indésirables), Antiviraux (usage thérapeutique), Enfant, Enfant d'âge préscolaire, Femelle, Grippe humaine (), Grippe humaine (soins infirmiers), Grippe humaine (épidémiologie), Humains, Mâle, Nourrisson, Oséltamivir (effets indésirables), Oséltamivir (usage thérapeutique), Saisons, Sialidase (antagonistes et inhibiteurs), Transmission de maladie infectieuse du professionnel de santé au patient (), Vaccins antigrippaux (administration et posologie), Vaccins antigrippaux (effets indésirables), Zanamivir (effets indésirables), Zanamivir (usage thérapeutique), Études transversales.
- MESH :
- administration et posologie : Vaccins antigrippaux.
- antagonistes et inhibiteurs : Sialidase.
- effets indésirables : Antiviraux, Oséltamivir, Vaccins antigrippaux, Zanamivir.
- soins infirmiers : Grippe humaine.
- usage thérapeutique : Antiviraux, Oséltamivir, Zanamivir.
- épidémiologie : Grippe humaine.
- Adolescent, Adulte, Adulte d'âge moyen, Allemagne, Enfant, Enfant d'âge préscolaire, Femelle, Grippe humaine, Humains, Mâle, Nourrisson, Saisons, Transmission de maladie infectieuse du professionnel de santé au patient, Études transversales.
- Wicri :
- geographic : Allemagne.
English descriptors
- KwdEn :
- Adolescent, Adult, Antiviral Agents (adverse effects), Antiviral Agents (therapeutic use), Child, Child, Preschool, Cross-Sectional Studies, Female, Germany, Humans, Infant, Infectious Disease Transmission, Professional-to-Patient (prevention & control), Influenza Vaccines (administration & dosage), Influenza Vaccines (adverse effects), Influenza, Human (epidemiology), Influenza, Human (nursing), Influenza, Human (prevention & control), Male, Middle Aged, Neuraminidase (antagonists & inhibitors), Oseltamivir (adverse effects), Oseltamivir (therapeutic use), Seasons, Zanamivir (adverse effects), Zanamivir (therapeutic use).
- MESH :
- chemical , administration & dosage : Influenza Vaccines.
- chemical , adverse effects : Antiviral Agents, Influenza Vaccines, Oseltamivir, Zanamivir.
- chemical , antagonists & inhibitors : Neuraminidase.
- chemical , therapeutic use : Antiviral Agents, Oseltamivir, Zanamivir.
- geographic : Germany.
- epidemiology : Influenza, Human.
- nursing : Influenza, Human.
- prevention & control : Infectious Disease Transmission, Professional-to-Patient, Influenza, Human.
- Adolescent, Adult, Child, Child, Preschool, Cross-Sectional Studies, Female, Humans, Infant, Male, Middle Aged, Seasons.
PubMed: 18380419
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Influenza in children: what should be considered in prevention and treatment?].</title><author><name sortKey="Panknin, Hardy Thorsten" sort="Panknin, Hardy Thorsten" uniqKey="Panknin H" first="Hardy-Thorsten" last="Panknin">Hardy-Thorsten Panknin</name><affiliation wicri:level="1"><nlm:affiliation>ht.panknin@tiscali.de</nlm:affiliation><country wicri:rule="url">Allemagne</country></affiliation></author><author><name sortKey="Trautmann, Matthias" sort="Trautmann, Matthias" uniqKey="Trautmann M" first="Matthias" last="Trautmann">Matthias Trautmann</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2008">2008</date><idno type="RBID">pubmed:18380419</idno><idno type="pmid">18380419</idno><idno type="wicri:Area/Main/Corpus">000441</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000441</idno><idno type="wicri:Area/Main/Curation">000441</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000441</idno><idno type="wicri:Area/Main/Exploration">000441</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Influenza in children: what should be considered in prevention and treatment?].</title><author><name sortKey="Panknin, Hardy Thorsten" sort="Panknin, Hardy Thorsten" uniqKey="Panknin H" first="Hardy-Thorsten" last="Panknin">Hardy-Thorsten Panknin</name><affiliation wicri:level="1"><nlm:affiliation>ht.panknin@tiscali.de</nlm:affiliation><country wicri:rule="url">Allemagne</country></affiliation></author><author><name sortKey="Trautmann, Matthias" sort="Trautmann, Matthias" uniqKey="Trautmann M" first="Matthias" last="Trautmann">Matthias Trautmann</name></author></analytic><series><title level="j">Kinderkrankenschwester : Organ der Sektion Kinderkrankenpflege</title><idno type="ISSN">0723-2276</idno><imprint><date when="2008" type="published">2008</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Antiviral Agents (adverse effects)</term><term>Antiviral Agents (therapeutic use)</term><term>Child</term><term>Child, Preschool</term><term>Cross-Sectional Studies</term><term>Female</term><term>Germany</term><term>Humans</term><term>Infant</term><term>Infectious Disease Transmission, Professional-to-Patient (prevention & control)</term><term>Influenza Vaccines (administration & dosage)</term><term>Influenza Vaccines (adverse effects)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (nursing)</term><term>Influenza, Human (prevention & control)</term><term>Male</term><term>Middle Aged</term><term>Neuraminidase (antagonists & inhibitors)</term><term>Oseltamivir (adverse effects)</term><term>Oseltamivir (therapeutic use)</term><term>Seasons</term><term>Zanamivir (adverse effects)</term><term>Zanamivir (therapeutic use)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Allemagne</term><term>Antiviraux (effets indésirables)</term><term>Antiviraux (usage thérapeutique)</term><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Femelle</term><term>Grippe humaine ()</term><term>Grippe humaine (soins infirmiers)</term><term>Grippe humaine (épidémiologie)</term><term>Humains</term><term>Mâle</term><term>Nourrisson</term><term>Oséltamivir (effets indésirables)</term><term>Oséltamivir (usage thérapeutique)</term><term>Saisons</term><term>Sialidase (antagonistes et inhibiteurs)</term><term>Transmission de maladie infectieuse du professionnel de santé au patient ()</term><term>Vaccins antigrippaux (administration et posologie)</term><term>Vaccins antigrippaux (effets indésirables)</term><term>Zanamivir (effets indésirables)</term><term>Zanamivir (usage thérapeutique)</term><term>Études transversales</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antiviral Agents</term><term>Influenza Vaccines</term><term>Oseltamivir</term><term>Zanamivir</term></keywords><keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>Neuraminidase</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term><term>Oseltamivir</term><term>Zanamivir</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Germany</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr"><term>Sialidase</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Antiviraux</term><term>Oséltamivir</term><term>Vaccins antigrippaux</term><term>Zanamivir</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="nursing" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Infectious Disease Transmission, Professional-to-Patient</term><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="soins infirmiers" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiviraux</term><term>Oséltamivir</term><term>Zanamivir</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Child</term><term>Child, Preschool</term><term>Cross-Sectional Studies</term><term>Female</term><term>Humans</term><term>Infant</term><term>Male</term><term>Middle Aged</term><term>Seasons</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Allemagne</term><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Femelle</term><term>Grippe humaine</term><term>Humains</term><term>Mâle</term><term>Nourrisson</term><term>Saisons</term><term>Transmission de maladie infectieuse du professionnel de santé au patient</term><term>Études transversales</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Allemagne</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">18380419</PMID><DateCompleted><Year>2008</Year><Month>05</Month><Day>16</Day></DateCompleted><DateRevised><Year>2016</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0723-2276</ISSN><JournalIssue CitedMedium="Print"><Volume>27</Volume><Issue>2</Issue><PubDate><Year>2008</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Kinderkrankenschwester : Organ der Sektion Kinderkrankenpflege</Title><ISOAbbreviation>Kinderkrankenschwester</ISOAbbreviation></Journal><ArticleTitle>[Influenza in children: what should be considered in prevention and treatment?].</ArticleTitle><Pagination><MedlinePgn>61-4</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Panknin</LastName><ForeName>Hardy-Thorsten</ForeName><Initials>HT</Initials><AffiliationInfo><Affiliation>ht.panknin@tiscali.de</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trautmann</LastName><ForeName>Matthias</ForeName><Initials>M</Initials></Author></AuthorList><Language>ger</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Influenza bei Kindern: Was ist bei Prävention und Behandlung zu bedenken?</VernacularTitle></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Kinderkrankenschwester</MedlineTA><NlmUniqueID>8305989</NlmUniqueID><ISSNLinking>0723-2276</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>20O93L6F9H</RegistryNumber><NameOfSubstance UI="D053139">Oseltamivir</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.1.18</RegistryNumber><NameOfSubstance UI="D009439">Neuraminidase</NameOfSubstance></Chemical><Chemical><RegistryNumber>L6O3XI777I</RegistryNumber><NameOfSubstance UI="D053243">Zanamivir</NameOfSubstance></Chemical></ChemicalList><CitationSubset>N</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017757" MajorTopicYN="N">Infectious Disease Transmission, Professional-to-Patient</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000451" MajorTopicYN="Y">nursing</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009439" MajorTopicYN="N">Neuraminidase</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053139" MajorTopicYN="N">Oseltamivir</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053243" MajorTopicYN="N">Zanamivir</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>4</Month><Day>3</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>5</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>4</Month><Day>3</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18380419</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Allemagne</li></country></list><tree><noCountry><name sortKey="Trautmann, Matthias" sort="Trautmann, Matthias" uniqKey="Trautmann M" first="Matthias" last="Trautmann">Matthias Trautmann</name></noCountry><country name="Allemagne"><noRegion><name sortKey="Panknin, Hardy Thorsten" sort="Panknin, Hardy Thorsten" uniqKey="Panknin H" first="Hardy-Thorsten" last="Panknin">Hardy-Thorsten Panknin</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeAllemagneV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000422 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000422 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= GrippeAllemagneV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:18380419
|texte= [Influenza in children: what should be considered in prevention and treatment?].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:18380419" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeAllemagneV3
| This area was generated with Dilib version V0.6.35. |  |